Drug Database
Back to search

Poland· PL-100090402

Activelle

A norethisteron und estrogen product containing estradiolum + norethisteronum, registered in Poland by Novo Nordisk A/S. The same ATC class is registered in 11 of our 19 countries.

ATC G03FA01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedActivelleATCG03FA01REGISTER NO.PL-100090402PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about estradiolum + norethisteronumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Norethisteron und estrogen is registered in 11 of 19 countries.

Countries holding a registration under ATC G03FA01 (norethisteron und estrogen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search norethisteron und estrogen products by name

Norethisteron und estrogen · ATC G03FA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Estradiolum + Norethisteronum
Manufacturer
Novo Nordisk A/S
Country
Poland (PL)
ATC code
G03FA01
ATC class
Norethisteron und Estrogen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    05909990451210
    28 szt.
    PLN 26.84

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

11 interactions on record for norethisteron und estrogen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check norethisteron und estrogen against other medicinesHow interaction checks work

Norethisteron und estrogen · interactions on record

11 records

11 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Norethisteron und estrogen in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All norethisteron und estrogen products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Activelle, Kliogest
  • Belgium · Activelle, Activelle Minor
  • Bulgaria · Активел, Трисеквенс
  • Cyprus · Trisequens
  • Czechia · Activelle, Kliogest
  • Germany · Activelle, Cliovelle
  • Denmark · Activelle, Activelle Low
  • Estonia · Activelle, Eviana
  • Spain · Activelle, Duofemme
  • Finland · Activelle, Cliovelle
  • France · Activelle, Kliogest
  • Greece · Trisequens
  • Croatia · Activelle, Novofem
  • Hungary · Activelle, Kliogest
  • Ireland · Activelle, Kliogest
  • Iceland · Activelle, Activelle Low
  • Italy · Activelle
  • Lithuania · Activelle, Kliogest
  • Luxembourg · Activelle, Activelle Minor
  • Latvia · Activelle, Kliogest
  • Netherlands · Activelle
  • Norway · Activelle, Cliovelle
  • Portugal · Activelle, Kliogest
  • Sweden · Activelle, Cliovelle
  • Slovenia · Activelle, Kliogest
  • Slovakia · Activelle, Novofem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1efa211c-435e-480f-8994-0d4020f8445e
GET /v1/drugs/1efa211c-435e-480f-8994-0d4020f8445e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "1 mg + 0,5 mg",
  "packaging": "05909990451210 ¦ Rp ¦ 14589\n28 tabl.",
  "substance": "Estradiolum 1 mg + Norethisteroni acetas 0.5 mg",
  "common_name": "Estradiolum + Norethisteronum",
  "pl_product_id": "100090402",
  "pozwolenie_nr": "04512",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about norethisteron und estrogen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console